AbbVie beats expectations with smaller Humira slide — and big gains for next autoimmune blockbusters

Humira isn’t going anywhere yet. And its successors are coming along nicely, too.

On Thursday, AbbVie shared second-quarter financial results that show its cornerstone immunology …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ESC 2024: Obesity drugs emerge as attractive tool for heart failure prevention – Pharmaceutical Technology

The European Society of Cardiology Congress 2024 is taking place in London 30 August- 2 September. Obesity is an independent risk factor for heart failure,

August 30, 2024

New state-of-the-art genomic services facility opening in the UK

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site.

December 8, 2023

International society criticizes Utah law for permitting unapproved stem cell therapies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.